BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+8.49%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.38T
AUM Growth
+$269B
(+8.7%)
Cap. Flow
+$78.2B
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
5,361
New
347
Increased
3,635
Reduced
827
Closed
107
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.09B |
| 2 |
Coupang
CPNG
|
+$1.89B |
| 3 |
Amazon
AMZN
|
+$1.51B |
| 4 |
International Flavors & Fragrances
IFF
|
+$1.29B |
| 5 |
ConocoPhillips
COP
|
+$1.16B |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$1.46B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.4B |
| 3 |
DuPont de Nemours
DD
|
+$960M |
| 4 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$852M |
| 5 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$809M |
Sector Composition
| 1 | Technology | 21.97% |
| 2 | Healthcare | 13.45% |
| 3 | Financials | 12.94% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Silvercrest Asset Management
SAMG
$137M
| $8.55M | ﹤0.01% |
594,411
+52,298
| +10% | +$752K |
|
3577
Nano X Imaging
NNOX
$249M
| $8.52M | ﹤0.01% |
205,508
+13,527
| +7% | +$561K |
|
|
CLPR
3578
Clipper Realty
CLPR
$70.6M
| $8.51M | ﹤0.01% |
1,074,171
+40,552
| +4% | +$321K |
|
|
MFNC
3579
DELISTED
Mackinac Financial Corporation
MFNC
| $8.5M | ﹤0.01% |
606,476
+69,274
| +13% | +$971K |
|
|
CBIO
3580
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $8.5M | ﹤0.01% |
28,236
+2,071
| +8% | +$623K |
|
3581
iShares Global Utilities ETF
JXI
$216M
| $8.44M | ﹤0.01% |
139,454
-7,266
| -5% | -$440K |
|
3582
Root
ROOT
$1.53B
| $8.38M | ﹤0.01% |
36,576
-6,613
| -15% | -$1.52M |
|
3583
Gyre Therapeutics
GYRE
$711M
| $8.33M | ﹤0.01% |
220,234
+40,581
| +23% | +$1.53M |
|
|
SOLY
3584
DELISTED
Soliton, Inc.
SOLY
| $8.3M | ﹤0.01% |
472,625
+6,385
| +1% | +$112K |
|
3585
Eagle Bancorp Montana
EBMT
$138M
| $8.29M | ﹤0.01% |
340,850
+65,251
| +24% | +$1.59M |
|
3586
Vasta Platform
VSTA
$364M
| $8.29M | ﹤0.01% |
841,644
-272,180
| -24% | -$2.68M |
|
|
ALR
3587
DELISTED
AlerisLife Inc. Common Stock
ALR
| $8.24M | ﹤0.01% |
1,347,179
+113,514
| +9% | +$695K |
|
|
BEST
3588
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $8.2M | ﹤0.01% |
218,100
+31,169
| +17% | +$1.17M |
|
|
KLDO
3589
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $8.18M | ﹤0.01% |
1,010,363
+71,732
| +8% | +$581K |
|
|
GMBTU
3590
DELISTED
Pivotal Holdings Corp Unit
GMBTU
| $8.16M | ﹤0.01% |
+808,824
| New | +$8.16M |
|
|
ASXC
3591
DELISTED
Asensus Surgical, Inc.
ASXC
| $8.16M | ﹤0.01% |
2,509,616
+1,905,705
| +316% | +$6.19M |
|
3592
Eastern Company
EML
$155M
| $8.1M | ﹤0.01% |
302,264
+12,093
| +4% | +$324K |
|
3593
Franklin Financial Services
FRAF
$212M
| $8.09M | ﹤0.01% |
259,443
+24,236
| +10% | +$756K |
|
3594
First Western Financial
MYFW
$228M
| $8.08M | ﹤0.01% |
322,958
+43,958
| +16% | +$1.1M |
|
3595
Embraer
ERJ
$10.5B
| $8.04M | ﹤0.01% |
+802,768
| New | +$8.04M |
|
3596
Meridian
MRBK
$171M
| $7.98M | ﹤0.01% |
614,124
+80,676
| +15% | +$1.05M |
|
3597
Aemetis
AMTX
$137M
| $7.98M | ﹤0.01% |
325,382
+308,977
| +1,883% | +$7.58M |
|
3598
Hawthorn Bancshares
HWBK
$222M
| $7.95M | ﹤0.01% |
420,238
+45,961
| +12% | +$870K |
|
3599
Eton Pharmaceutcials
ETON
$473M
| $7.95M | ﹤0.01% |
1,086,266
+33,321
| +3% | +$244K |
|
|
ADAP
3600
Adaptimmune Therapeutics
ADAP
$14.8M
| $7.94M | ﹤0.01% |
1,494,346
+39,472
| +3% | +$210K |
|